Skip to main content

Table 1 Baseline patient characteristics

From: Glucose metabolism after distal pancreatectomy - deterioration of beta cell function becomes noticeable at an early stage: a retrospective cohort study

Variable

Overall

ND

IFG/IGT

DM

p-Value *

Patients [n] (%)

69

17 (24.6)

22 (31.9)

30 (43.5)

 

Sex [n] (%)

     

 M

 W

31 (44.8)

38 (55.1)

5 (29.4)

12 (70.6)

9 (40.9)

13 (59.1)

17 (56.7)

13 (43.3)

0.18

Median age [years] (IQR)

65 (56–73)

58 (42–68)

62 (56.8–70.3)

71 (58.8–78)

< 0.01

Median BMI [kg/m²] (IQR)

25.8 (23.3–29)

23.4 (21.4–25.4)

25.5 (23.8–28.1)

27 (25.1–30.4)

0.02

Smoking [n] (%)

12 (17.4)

6 (35.3)

4 (18.2)

2 (6.7)

< 0.05

Alcohol [n] (%)

5 (7.2)

2 (11.8)

3 (13.6)

0

0.12

Weight loss [n] (%)

24 (34.8)

6 (35.3)

5 (22.7)

13 (43.3)

0.3

HTN [n] (%)

42 (60.9)

6 (35.3)

12 (54.5)

24 (80)

< 0.01

CHF [n] (%)

14 (20.3)

3 (17.6)

1 (4.5)

10 (33.3)

0.04

CHD [n] (%)

9 (13)

0

2 (9.1)

7 (23.3)

0.06

CKD [n] (%)

17 (24.6)

2 (11.8)

4 (18.2)

11 (36.7)

0.11

IDDM [n] (%)

14 (20.3)

0

0

14 (46.7)

n.a.

OHA [n] (%)

13 (18.8)

0

0

13 (43.3)

n.a.

ASA [n] (%)

     

 ASA 1

 ASA 2

 ASA 3

 ASA 4

6 (8.7)

35 (50.7)

27 (39.1)

1 (1.4)

3 (17.6)

10 (58.8)

4 (23.5)

0

2 (9.1)

14 (63.6)

6 (27.3)

0

1 (3.3)

11 (36.7)

17 (56.7)

1 (3.3)

0.12

  1. * One-way analysis of variance (ANOVA) with repeated measurements, p-value refers to analysis across all timepoints
  2. Abbreviations: ASA - American Society of Anesthesiologists; BMI - Body Mass Index; CHD - coronary heart disease; CHF - chronic heart failure; CKD - chronic kidney disease; DM - diabetes mellitus; IDDM - insulin-dependent diabetes mellitus, IFG/IGT - impaired fasting glucose/impaired glucose tolerance; IQR - interquartile range; HTN - arterial hypertension; NG - normoglycemic; OHA - oral hypoglycemic agents